loading
Schlusskurs vom Vortag:
$1.26
Offen:
$1.28
24-Stunden-Volumen:
251.67K
Relative Volume:
0.65
Marktkapitalisierung:
$104.16M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.5645
EPS:
-2.17
Netto-Cashflow:
$-102.08M
1W Leistung:
-2.78%
1M Leistung:
-20.45%
6M Leistung:
-58.75%
1J Leistung:
-11.87%
1-Tages-Spanne:
Value
$1.20
$1.28
1-Wochen-Bereich:
Value
$1.20
$1.31
52-Wochen-Spanne:
Value
$1.14
$5.51

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
Firmenname
Century Therapeutics Inc
Name
Telefon
215-981-4000
Name
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
Mitarbeiter
165
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
IPSC's Discussions on Twitter

Vergleichen Sie IPSC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
IPSC 1.225 104.16M 2.24M -136.67M -102.08M -2.17
VRTX 449.81 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.02 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 594.70 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.85 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.66 24.89B 3.30B -501.07M 1.03B 11.54

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-12-27 Eingeleitet Chardan Capital Markets Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-05-23 Eingeleitet H.C. Wainwright Buy
2022-05-12 Eingeleitet William Blair Mkt Perform
2021-07-13 Eingeleitet BofA Securities Buy
2021-07-13 Eingeleitet JP Morgan Overweight
2021-07-13 Eingeleitet Piper Sandler Overweight
Alle ansehen

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

pulisher
Nov 20, 2024

Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024 - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire

Nov 19, 2024
pulisher
Nov 19, 2024

Endo, Inc. Partners with MC2 Therapeutics to Bring Wynzora® Cream to Canadian Market - MyChesCo

Nov 19, 2024
pulisher
Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024
pulisher
Nov 14, 2024

Syncona Portfolio Ltd's Strategic Acquisition of Autolus Therape - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

FMR LLC's Strategic Reduction in Century Therapeutics Inc Holdin - GuruFocus.com

Nov 13, 2024
pulisher
Nov 11, 2024

NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 11, 2024
pulisher
Nov 11, 2024

Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy - MyChesCo

Nov 11, 2024
pulisher
Nov 11, 2024

Century Therapeutics to Present Cutting-Edge Preclinical Data at 2024 ASH Annual Meeting - MSN

Nov 11, 2024
pulisher
Nov 10, 2024

Ocugen Advances Gene Therapy and Financial Strategies in Q3 2024 - MyChesCo

Nov 10, 2024
pulisher
Nov 09, 2024

William Blair Has Positive Estimate for IPSC FY2024 Earnings - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Palvella Therapeutics Begins Phase 3 Trial for Microcystic Lymphatic Malformations Treatment - MyChesCo

Nov 09, 2024
pulisher
Nov 09, 2024

Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 09, 2024
pulisher
Nov 09, 2024

FY2024 Earnings Estimate for IPSC Issued By HC Wainwright - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Context Therapeutics Announces Q3 2024 Financial Results and Strategic Advances - MyChesCo

Nov 08, 2024
pulisher
Nov 08, 2024

What Makes Century Therapeutics (IPSC) a New Buy Stock - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

What is HC Wainwright's Forecast for IPSC FY2024 Earnings? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

William Blair Has Strong Estimate for IPSC FY2024 Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Cabaletta Bio to Spotlight Groundbreaking Cell Therapies at Guggenheim's Healthcare Innovation Conference! - MyChesCo

Nov 08, 2024
pulisher
Nov 08, 2024

Aclaris Therapeutics Highlights Key Advances and Financial Results for Q3 2024 - MyChesCo

Nov 08, 2024
pulisher
Nov 08, 2024

Passage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference! - MyChesCo

Nov 08, 2024
pulisher
Nov 07, 2024

Chardan Capital Has Lowered Expectations for Century Therapeutics (NASDAQ:IPSC) Stock Price - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Join Century Therapeutics at Guggenheim’s Healthcare Innovation Conference! - MyChesCo

Nov 06, 2024
pulisher
Nov 06, 2024

Century Therapeutics shares target cut, retains Buy rating on updated data - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

HC Wainwright Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Century Therapeutics COO sells $1,267 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

Century Therapeutics Reports Q3 Results & Strategic Updates - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Century Therapeutics COO sells $1,267 in stock By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Century Therapeutics earnings beat by $0.08, revenue topped estimates - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

InventHelp Inventor Develops Protective Accessory for Underwear (ASP-336) - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Ichnos Glenmark Innovation (IGI) Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma (r/rMM) at Upcoming ASH Annual Meeting - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of - The Bakersfield Californian

Nov 05, 2024
pulisher
Nov 05, 2024

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting - Yahoo Finance

Nov 05, 2024
pulisher
Nov 04, 2024

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference - GlobeNewswire

Nov 04, 2024
pulisher
Oct 31, 2024

Larimar Therapeutics Reports Third-Quarter 2024 Financial and Operational Progress - MyChesCo

Oct 31, 2024
pulisher
Oct 28, 2024

We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate - Yahoo Finance

Oct 28, 2024
pulisher
Oct 25, 2024

Context Therapeutics to Engage Investors at November Conferences - MyChesCo

Oct 25, 2024
pulisher
Oct 22, 2024

electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? - Yahoo Finance

Oct 22, 2024
pulisher
Oct 17, 2024

Context Therapeutics to Showcase Promising Cancer Therapy at SITC Annual Meeting - MyChesCo

Oct 17, 2024
pulisher
Oct 16, 2024

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 6.4% in September - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

As the Cell Therapy Market Eyes $48 Billion, Bayer Invests $215 Million in Century Therapeutics As Revealed... - WhaTech

Oct 16, 2024
pulisher
Oct 15, 2024

Dimensional Fund Advisors LP Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Oct 15, 2024
pulisher
Oct 15, 2024

Artiva, Century, others extend natural-killer autoimmune push - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Ubiquiti Inc. (NYSE:UI) Shares Sold by Dimensional Fund Advisors LP - Defense World

Oct 15, 2024
pulisher
Oct 05, 2024

American Century Companies Inc. Has $128,000 Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Oct 05, 2024

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):